People In Brief: Elizabeth Arden, Ronkin Part Ways; Lauder Execs Advance; More
This article was originally published in The Rose Sheet
Executive Summary
LUXE Brands and Fekkai Brands, which the former created through a joint venture earlier this year to acquire the Frederic Fekkai brand from P&G, will be led by Joel Ronkin, who has left Elizabeth Arden after 16 years of service. More people news.
You may also be interested in...
In Brief: Contamination Recall; ‘Made In America’ Questioned; More
Contract manufacturer Sensible Organics recalls Nourish Organic facial skin-care items due to potential contamination; Revlon's "Almay Simply American" marketing comes under fire for alleged deception. More news in brief.
Sliding Scale: Bar For COVID Therapeutics EUAs ‘Can Be Somewhat Variable’ – FDA’s Peter Marks
Marks appeared to use the variable EUA bar to justify what many viewed as early mistakes by FDA during COVID-19, and to emphasize the importance of physician awareness of the strength of evidence used to authorize a drug.
Can US FDA Share Drug Sponsor’s Information With Patent & Trademark Office?
Patent office could request information from FDA that is material to patentability, speakers at USPTO-FDA ‘listening session’ advise the agencies. Information exchange raises questions about trade secret protection and burdens on agencies.